Skip to main content

Table 6 Predictive factors for overall survival after comparing the expected group and the group with the worst response to therapy

From: A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy

 

Univariate

Multivariate

    

MSKCC risk patients

Heng risk patients

Variables

OR

P-value

95 % CI

HR

P-value

95 % CI

HR

P-value

95 % CI

Age

1.03

0.099

0.99–1.06

1.05

0.045

1.01–1.10

   

Hemoglobin low

6.46

0.000

2.74–15.22

4.13

0.008

1.44–11.8

4.61

0.003

1.68–12.66

Lymphocyte high

0.36

0.368

0.04–15.22

0.22

0.215

0.02–2.42

0.18

0.160

0.02–1.95

Low

13.16

0.000

4.18–9.34

4.76

0.022

1.25–18.17

5.26

0.012

1.44–19.14

DFI < 1 year

3.81

0.007

1.43–10.15

4.80

0.036

1.10–20.9

   

synchronous metastasis

4.68

0.001

1.85–11.84

3.52

0.039

1.07–11.61

3.17

0.057

0.97–10.41